Skip to main content
Erschienen in: International Urogynecology Journal 1/2014

01.01.2014 | Original Article

Ethnicity and variations of pelvic organ prolapse bother

verfasst von: Gena C. Dunivan, Sara B. Cichowski, Yuko M. Komesu, Pamela S. Fairchild, Jennifer T. Anger, Rebecca G. Rogers

Erschienen in: International Urogynecology Journal | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

To determine if prolapse symptom severity and bother varies among non-Hispanic white, Hispanic, and Native American women with equivalent prolapse stages on physical examination.

Methods

This was a retrospective chart review of new patients seen in an academic urogynecology clinic from January 2007 to September 2011. Data were extracted from a standardized intake form, including patients’ self-identified ethnicity. All patients underwent a Pelvic Organ Prolapse Quantification (POPQ) examination and completed the Pelvic Floor Distress Inventory-20 (PFDI-20) with its Pelvic Organ Prolapse Distress Inventory (POPDI) subscale.

Results

Five hundred and eighty-eight new patients were identified with pelvic organ prolapse. Groups did not differ by age, prior prolapse, and/or incontinence surgery, or sexual activity. Based on POPDI scores, Hispanic and Native American women reported more bother compared with non-Hispanic white women with stage 2 prolapse (p < 0.01). Level of bother between Hispanic and Native American women with stage 2 prolapse (p = 0.56) was not different. In subjects with ≥ stage 3 prolapse, POPDI scores did not differ by ethnicity (p = 0.24). In multivariate stepwise regression analysis controlling for significant factors, Hispanic and Native American ethnicity contributed to higher POPDI scores, as did depression.

Conclusions

Among women with stage 2 prolapse, both Hispanic and Native American women had a higher level of bother, as measured by the POPDI, compared with non-Hispanic white women. The level of symptom bother was not different between ethnicities in women with stage 3 prolapse or greater. Disease severity may overshadow ethnic differences at more advanced stages of prolapse.
Literatur
1.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victro A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49PubMedCrossRef Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victro A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49PubMedCrossRef
2.
Zurück zum Zitat Brincat CA, Larson KA, Fenner DE (2010) Anterior vaginal wall prolapse: assessment and treatment. Clin Obstet Gynecol 53:51–58PubMedCrossRef Brincat CA, Larson KA, Fenner DE (2010) Anterior vaginal wall prolapse: assessment and treatment. Clin Obstet Gynecol 53:51–58PubMedCrossRef
3.
Zurück zum Zitat Kudish BI, Iglesia CB (2010) Posterior wall prolapse and repair. Clin Obstet Gynecol 53:59–71PubMedCrossRef Kudish BI, Iglesia CB (2010) Posterior wall prolapse and repair. Clin Obstet Gynecol 53:59–71PubMedCrossRef
4.
Zurück zum Zitat Lowder JL, Ghetti C, Moalli P, Zyczynski H, Cash TF (2010) Body image in women before and after reconstructive surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 21:919–925CrossRef Lowder JL, Ghetti C, Moalli P, Zyczynski H, Cash TF (2010) Body image in women before and after reconstructive surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 21:919–925CrossRef
5.
Zurück zum Zitat Jelovsek JE, Barber MD (2006) Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 194:1455–1461PubMedCrossRef Jelovsek JE, Barber MD (2006) Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 194:1455–1461PubMedCrossRef
6.
Zurück zum Zitat Kammerer-Doak D (2009) Assessment of sexual function in women with pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 20 [Suppl 1]:S45–S50PubMedCrossRef Kammerer-Doak D (2009) Assessment of sexual function in women with pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 20 [Suppl 1]:S45–S50PubMedCrossRef
7.
Zurück zum Zitat Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186:1160–1166PubMedCrossRef Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186:1160–1166PubMedCrossRef
8.
Zurück zum Zitat Sung VW, Hampton BS (2009) Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am 36:421–443PubMedCrossRef Sung VW, Hampton BS (2009) Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am 36:421–443PubMedCrossRef
9.
Zurück zum Zitat Bump RC, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P, Shull B, Smith A (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMedCrossRef Bump RC, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P, Shull B, Smith A (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMedCrossRef
10.
Zurück zum Zitat Kingsberg S, Althof SE (2009) Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 20 [Suppl 1]:S33–S43PubMedCrossRef Kingsberg S, Althof SE (2009) Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 20 [Suppl 1]:S33–S43PubMedCrossRef
11.
Zurück zum Zitat Basson R, Wierman ME, van Lankveld J, Brotto L (2010) Summary of the recommendations on sexual dysfunctions in women. J Sex Med 7:314–326PubMedCrossRef Basson R, Wierman ME, van Lankveld J, Brotto L (2010) Summary of the recommendations on sexual dysfunctions in women. J Sex Med 7:314–326PubMedCrossRef
12.
Zurück zum Zitat Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE (2001) Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 185:1332–1337, discussion 7–8PubMedCrossRef Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE (2001) Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 185:1332–1337, discussion 7–8PubMedCrossRef
13.
Zurück zum Zitat Swift SE, Tate SB, Nicholas J (2003) Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol 189:372–377, discussion 7–9PubMedCrossRef Swift SE, Tate SB, Nicholas J (2003) Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol 189:372–377, discussion 7–9PubMedCrossRef
14.
Zurück zum Zitat Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK, Subak LL (2009) Racial differences in pelvic organ prolapse. Obstet Gynecol 114:1271–1277PubMedCentralPubMedCrossRef Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK, Subak LL (2009) Racial differences in pelvic organ prolapse. Obstet Gynecol 114:1271–1277PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113PubMedCrossRef Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113PubMedCrossRef
16.
Zurück zum Zitat Barber MD, Spino C, Janz NK, Brubaker L, Nygaard I, Nager CW, Wheeler TL (2009) The minimum important differences for the urinary scales of the pelvic floor distress inventory and pelvic floor impact questionnaire; Pelvic Floor Disorders Network. Am J Obstet Gynecol 200(5):580.e1–580.e7CrossRef Barber MD, Spino C, Janz NK, Brubaker L, Nygaard I, Nager CW, Wheeler TL (2009) The minimum important differences for the urinary scales of the pelvic floor distress inventory and pelvic floor impact questionnaire; Pelvic Floor Disorders Network. Am J Obstet Gynecol 200(5):580.e1–580.e7CrossRef
17.
Zurück zum Zitat Ghetti C, Lowder JL, Ellison R, Krohn MA, Moalli P (2010) Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J 21(7):855–860PubMedCentralPubMedCrossRef Ghetti C, Lowder JL, Ellison R, Krohn MA, Moalli P (2010) Depressive symptoms in women seeking surgery for pelvic organ prolapse. Int Urogynecol J 21(7):855–860PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Fenner DE, Trowbridge ER, Patel DA, Fultz NH, Miller JM, Howard D, DeLancey JO (2008) Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol 179:1455–1460PubMedCentralPubMedCrossRef Fenner DE, Trowbridge ER, Patel DA, Fultz NH, Miller JM, Howard D, DeLancey JO (2008) Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol 179:1455–1460PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Lewicky-Gaupp C, Brincat C, Trowbridge ER, DeLancey JO, Guire K, Patel DA, Fenner DE (2009) Racial differences in bother for women with urinary incontinence in the Establishing the Prevalence of Incontinence (EPI) study. Am J Obstet Gynecol 201:510 e1–510 e6CrossRef Lewicky-Gaupp C, Brincat C, Trowbridge ER, DeLancey JO, Guire K, Patel DA, Fenner DE (2009) Racial differences in bother for women with urinary incontinence in the Establishing the Prevalence of Incontinence (EPI) study. Am J Obstet Gynecol 201:510 e1–510 e6CrossRef
20.
Zurück zum Zitat Daneshgari F, Imrey PB, Risendal B, Dwyer A, Barber MD, Byers T (2008) Differences in urinary incontinence between Hispanic and non-Hispanic white women: a population-based study. BJU Int 101:575–579PubMedCrossRef Daneshgari F, Imrey PB, Risendal B, Dwyer A, Barber MD, Byers T (2008) Differences in urinary incontinence between Hispanic and non-Hispanic white women: a population-based study. BJU Int 101:575–579PubMedCrossRef
21.
Zurück zum Zitat Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–1316PubMedCentralPubMedCrossRef Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–1316PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Bump RC (1993) Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol 81:421–425PubMed Bump RC (1993) Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol 81:421–425PubMed
23.
Zurück zum Zitat Graham CA, Mallett VT (2001) Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 185:116–120PubMedCrossRef Graham CA, Mallett VT (2001) Race as a predictor of urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 185:116–120PubMedCrossRef
Metadaten
Titel
Ethnicity and variations of pelvic organ prolapse bother
verfasst von
Gena C. Dunivan
Sara B. Cichowski
Yuko M. Komesu
Pamela S. Fairchild
Jennifer T. Anger
Rebecca G. Rogers
Publikationsdatum
01.01.2014
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 1/2014
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-013-2145-4

Weitere Artikel der Ausgabe 1/2014

International Urogynecology Journal 1/2014 Zur Ausgabe

Urogynecology Digest

Urogynecology Digest

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.